CLINICAL_TRIALS
trial_result
· 2024-03-19
Clinical Trial Update: Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain [Phase 2]
Summary
Phase 2 dose-ranging study investigating intravenous oxytocin for analgesia to heat pain in healthy volunteers has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Healthy Volunteer Study | Phase 2 | Status: COMPLETED | Results posted: 2024-03-19